Top Indian pharmaceutical leaders are urging a significant boost in research and development. They believe this focus on innovation is crucial for India to become a global biopharma manufacturing hub. Leaders from Sun Pharma, Cipla, Dr Reddy's Laboratories, and Lupin highlighted the need for greater investment and a shift towards developing novel drugs.
